Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 265

1.

Physical activity, sleep and cardiovascular health data for 50,000 individuals from the MyHeart Counts Study.

Hershman SG, Bot BM, Shcherbina A, Doerr M, Moayedi Y, Pavlovic A, Waggott D, Cho MK, Rosenberger ME, Haskell WL, Myers J, Champagne MA, Mignot E, Salvi D, Landray M, Tarassenko L, Harrington RA, Yeung AC, McConnell MV, Ashley EA.

Sci Data. 2019 Apr 11;6(1):24. doi: 10.1038/s41597-019-0016-7.

2.

A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing.

Zastrow DB, Kohler JN, Bonner D, Reuter CM, Fernandez L, Grove ME, Fisk DG; Undiagnosed Diseases Network, Yang Y, Eng CM, Ward PA, Bick D, Worthey EA, Fisher PG, Ashley EA, Bernstein JA, Wheeler MT 3rd.

J Genet Couns. 2019 Apr;28(2):213-228. doi: 10.1002/jgc4.1119.

PMID:
30964584
3.

Time to switch from CLSI to EUCAST? A Southeast Asian perspective.

Cusack TP, Ashley EA, Ling CL, Roberts T, Turner P, Wangrangsimakul T, Dance DAB.

Clin Microbiol Infect. 2019 Mar 25. pii: S1198-743X(19)30118-1. doi: 10.1016/j.cmi.2019.03.016. [Epub ahead of print]

PMID:
30922928
4.

Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data.

Turner P, Fox-Lewis A, Shrestha P, Dance DAB, Wangrangsimakul T, Cusack TP, Ling CL, Hopkins J, Roberts T, Limmathurotsakul D, Cooper BS, Dunachie S, Moore CE, Dolecek C, van Doorn HR, Guerin PJ, Day NPJ, Ashley EA.

BMC Med. 2019 Mar 29;17(1):70. doi: 10.1186/s12916-019-1301-1.

5.

Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy.

Kahn-Kirby AH, Amagata A, Maeder CI, Mei JJ, Sideris S, Kosaka Y, Hinman A, Malone SA, Bruegger JJ, Wang L, Kim V, Shrader WD, Hoff KG, Latham JC, Ashley EA, Wheeler MT, Bertini E, Carrozzo R, Martinelli D, Dionisi-Vici C, Chapman KA, Enns GM, Gahl W, Wolfe L, Saneto RP, Johnson SC, Trimmer JK, Klein MB, Holst CR.

PLoS One. 2019 Mar 28;14(3):e0214250. doi: 10.1371/journal.pone.0214250. eCollection 2019.

6.

Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.

Kumar A, Zastrow DB, Kravets EJ, Beleford D, Ruzhnikov MRZ, Grove ME, Dries AM, Kohler JN, Waggott DM, Yang Y, Huang Y; Undiagnosed Diseases Network, Mackenzie KM, Eng CM, Fisher PG, Ashley EA, Teng JM, Stevenson DA, Shieh JT, Wheeler MT, Bernstein JA.

Am J Med Genet A. 2019 Mar 28. doi: 10.1002/ajmg.a.61134. [Epub ahead of print]

PMID:
30920161
7.

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance.

Cusack TP, Ashley EA, Ling CL, Rattanavong S, Roberts T, Turner P, Wangrangsimakul T, Dance DAB.

Clin Microbiol Infect. 2019 Mar 22. pii: S1198-743X(19)30109-0. doi: 10.1016/j.cmi.2019.03.007. [Epub ahead of print]

PMID:
30910717
8.

Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".

Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Lakdawala NK, Ware JS, Helms AS, Colan SD, Seidman CE, Olivotto I; SHaRe Investigators.

Circulation. 2019 Mar 19;139(12):1559-1560. doi: 10.1161/CIRCULATIONAHA.118.039069. No abstract available.

PMID:
30883221
9.

Rapid Genome Sequencing in the Critically lll.

Buchan JG, White S, Joshi R, Ashley EA.

Clin Chem. 2019 Mar 6. pii: clinchem.2018.293506. doi: 10.1373/clinchem.2018.293506. [Epub ahead of print] No abstract available.

PMID:
30842082
10.

Plasmodium vivax relapse rates following falciparum malaria reflect previous transmission intensity.

Ashley EA, Phyo AP, Carrara VI, Tun KM, Nosten F, Smithuis F, White NJ.

J Infect Dis. 2019 Jan 29. doi: 10.1093/infdis/jiz052. [Epub ahead of print]

PMID:
30698794
11.

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

Intharabut B, Kingston HW, Srinamon K, Ashley EA, Imwong M, Dhorda M, Woodrow C, Stepniewska K, Silamut K, Day NPJ, Dondorp AM, White NJ; Tracking Resistance to Artemisinin Collaboration.

J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.

12.

Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings.

Dailey PJ, Osborn J, Ashley EA, Baron EJ, Dance DAB, Fusco D, Fanello C, Manabe YC, Mokomane M, Newton PN, Tessema B, Isaacs C, Dittrich S.

Diagnostics (Basel). 2019 Jan 11;9(1). pii: E10. doi: 10.3390/diagnostics9010010.

13.

Presence of Burkholderia pseudomallei in the 'Granary of Myanmar'.

Win TT, Su KK, Than AM, Htut ZM, Pyar KP, Ashley EA, Dance DAB, Tun KM.

Trop Med Infect Dis. 2019 Jan 4;4(1). pii: E8. doi: 10.3390/tropicalmed4010008.

14.

A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.

Seeger T, Shrestha R, Lam CK, Chen C, McKeithan WL, Lau E, Wnorowski A, McMullen G, Greenhaw M, Lee J, Oikonomopoulos A, Lee S, Yang H, Mercola M, Wheeler M, Ashley EA, Yang F, Karakikes I, Wu JC.

Circulation. 2019 Feb 5;139(6):799-811. doi: 10.1161/CIRCULATIONAHA.118.034624.

PMID:
30586709
15.

Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings.

Ashley EA, Shetty N, Patel J, van Doorn R, Limmathurotsakul D, Feasey NA, Okeke IN, Peacock SJ.

J Antimicrob Chemother. 2019 Mar 1;74(3):541-546. doi: 10.1093/jac/dky487.

16.

Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.

Lee SP, Ashley EA, Homburger J, Caleshu C, Green EM, Jacoby D, Colan SD, Arteaga-Fernández E, Day SM, Girolami F, Olivotto I, Michels M, Ho CY, Perez MV; SHaRe Investigators.

Circ Heart Fail. 2018 Sep;11(9):e005191. doi: 10.1161/CIRCHEARTFAILURE.118.005191.

PMID:
30354366
17.

Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar.

McLean ARD, Wai HP, Thu AM, Khant ZS, Indrasuta C, Ashley EA, Kyaw TT, Day NPJ, Dondorp A, White NJ, Smithuis FM.

BMC Med. 2018 Oct 22;16(1):183. doi: 10.1186/s12916-018-1172-x.

18.

Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.

Splinter K, Adams DR, Bacino CA, Bellen HJ, Bernstein JA, Cheatle-Jarvela AM, Eng CM, Esteves C, Gahl WA, Hamid R, Jacob HJ, Kikani B, Koeller DM, Kohane IS, Lee BH, Loscalzo J, Luo X, McCray AT, Metz TO, Mulvihill JJ, Nelson SF, Palmer CGS, Phillips JA 3rd, Pick L, Postlethwait JH, Reuter C, Shashi V, Sweetser DA, Tifft CJ, Walley NM, Wangler MF, Westerfield M, Wheeler MT, Wise AL, Worthey EA, Yamamoto S, Ashley EA; Undiagnosed Diseases Network.

N Engl J Med. 2018 Nov 29;379(22):2131-2139. doi: 10.1056/NEJMoa1714458. Epub 2018 Oct 10.

PMID:
30304647
19.

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).

Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I.

Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.

20.

Melioidosis in Myanmar.

Win MM, Ashley EA, Zin KN, Aung MT, Swe MMM, Ling CL, Nosten F, Thein WM, Zaw NN, Aung MY, Tun KM, Dance DAB, Smithuis FM.

Trop Med Infect Dis. 2018 Mar 1;3(1). pii: E28. doi: 10.3390/tropicalmed3010028. Review.

Supplemental Content

Loading ...
Support Center